| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/1996 | WO1996002499A1 Difluorostatone antiviral agents |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002488A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 02/01/1996 | WO1996002288A1 Process for preventing activation of enzyme systems in haemodialysis and in similar procedures with extracorporeal blood circulation |
| 02/01/1996 | WO1996002277A1 Solid drug forms containing clathrates of steroid sex hormones |
| 02/01/1996 | WO1996002275A1 Sustained-release oral ointment |
| 02/01/1996 | WO1996002274A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | WO1996002271A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | WO1996002268A1 Inhibition of virus by nitric oxide |
| 02/01/1996 | WO1996002265A1 The cellular basis of transplant arteriosclerosis |
| 02/01/1996 | WO1996002263A1 Blood sugar regulating compositions containing inulin and one or more metal complexes |
| 02/01/1996 | WO1996002260A1 Wound healing agent |
| 02/01/1996 | WO1996002259A1 Hard tissue stimulating agent |
| 02/01/1996 | WO1996002258A1 Anti-adhesion agent |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | WO1996002254A1 SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16 alpha ,17 alpha -ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES |
| 02/01/1996 | WO1996002253A1 Dioxolenylmethyl carbamates promoieties for amine drugs |
| 02/01/1996 | WO1996002252A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA |
| 02/01/1996 | WO1996002251A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | WO1996002250A1 Haloperidol analogs and the use thereof |
| 02/01/1996 | WO1996002249A1 Use of thiazole and thiadiazole compounds as d3 dopamine receptor ligands |
| 02/01/1996 | WO1996002248A1 Cannabinoid receptor antagonists |
| 02/01/1996 | WO1996002247A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 02/01/1996 | WO1996002246A1 Use of heterocyclic compounds as dopamines-d3 ligands |
| 02/01/1996 | WO1996002245A1 Nitric oxide synthase inhibitors for inhibiting the production of airway mucus |
| 02/01/1996 | WO1996002244A1 A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus |
| 02/01/1996 | WO1996002243A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 02/01/1996 | WO1996002242A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 02/01/1996 | WO1996002241A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| 02/01/1996 | WO1996002240A2 Use of inhibitors of human s-cd23 |
| 02/01/1996 | WO1996002238A1 Neurotropic and sedative agent and a method of obtaining the same |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 02/01/1996 | WO1996002231A1 Inhalation composition |
| 02/01/1996 | WO1996002229A2 Soap composition |
| 02/01/1996 | WO1996002226A1 Novel combination product comprising an antifungal agent and crotamiton as an antifungal activity enhancer and dermatological or cosmetic compositions comprising same |
| 02/01/1996 | WO1996002139A1 Method for treating anxiety |
| 02/01/1996 | WO1996002137A1 Wound healing formula |
| 02/01/1996 | WO1995035112A3 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 02/01/1996 | WO1995026739A3 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions |
| 02/01/1996 | DE4430449C1 Versprühbare filmbildende Wirkstoffabgabesysteme zur Anwendung an Pflanzen Sprayable film-forming drug delivery systems for use on plants |
| 02/01/1996 | DE4426601A1 Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri Use of a combination product comprising a competitive progesterone antagonist and a progestin for the manufacture of a medicament for treating endometriosis or leiomyomata uteri of |
| 02/01/1996 | DE19527140A1 Sprühbare Lösungen mit blutdrucksenkender Wirkung und Verfahren zu ihrer Herstellung sowie ihre Verwendung Sprayable solutions with antihypertensive effect and process for their preparation and their use |
| 02/01/1996 | DE19526163A1 New ganciclovir mono:esters and intermediates |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2200067A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2195444A1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 02/01/1996 | CA2195443A1 Piperazine thiopyridines for controlling helicobacter bacteria |
| 02/01/1996 | CA2195427A1 Novel aryl piperazine-derived piperazide derivatives, methods for their preparation, their use as drugs and pharmaceutical compositions comprising same |
| 02/01/1996 | CA2195397A1 Oligonucleotides with anti-mdr-1 gene activity |
| 02/01/1996 | CA2195345A1 Use of (s)-adenosyl-l-methionine (same) and its physiologically compatible salts for treating reperfusion damage triggered by temporary focal ischaemia |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195242A1 The use of heterocyclic compounds |
| 02/01/1996 | CA2195241A1 Substituted pyrimidine compounds and their use |
| 02/01/1996 | CA2195240A1 The use of thiazole and thiadiazole compounds |
| 02/01/1996 | CA2195239A1 Optically active isomers of dihydrexidine and its substituted analogs |
| 02/01/1996 | CA2195122A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 02/01/1996 | CA2195120A1 Wound healing formula |
| 02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
| 02/01/1996 | CA2195082A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 02/01/1996 | CA2195072A1 Sustained-release oral ointment |
| 02/01/1996 | CA2194991A1 Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| 02/01/1996 | CA2194889A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | CA2194771A1 Heterocyclic- and carbocyclic-substituted benzoic acids and synthesis thereof |
| 02/01/1996 | CA2194684A1 Cannabinoid receptor antagonists |
| 02/01/1996 | CA2194558A1 Conjugates made of metal complexes and oligonucleotides |
| 02/01/1996 | CA2194435A1 Trifluoromethylquinolinecarboxylic acid derivative |
| 02/01/1996 | CA2194398A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/01/1996 | CA2193661A1 Dioxolenylmethyl carbamates promoieties for amine drugs |
| 02/01/1996 | CA2192478A1 Quinoline derivatives as leukotriene antagonists |
| 02/01/1996 | CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 02/01/1996 | CA2171850A1 Novel compound having platelet aggregation inhibitor effect |
| 01/31/1996 | EP0694559A2 2',5'-Phosphorothioate oligoadenylates and antiviral uses thereof |
| 01/31/1996 | EP0694547A2 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694544A1 Benzofuranyl- and benzothienyloxazolidinones |
| 01/31/1996 | EP0694543A1 6-membered N-heteroaryloxazolidinones |
| 01/31/1996 | EP0694542A1 Process for racemisation of enantiomers of alpha-lipoic acid |
| 01/31/1996 | EP0694539A1 7-o-Ethers of taxane derivatives |
| 01/31/1996 | EP0694537A1 Heterocyclyloxy- benzoylguanidine derivatives, their preparation and their use as inhibitors of the cellular Na+/H+-antiporter |
| 01/31/1996 | EP0694536A1 1-Benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them |
| 01/31/1996 | EP0694535A1 Non-peptidyl tachykinin receptor antagonists |
| 01/31/1996 | EP0694521A1 Ketotricyclo(5.2.1.0)decane derivatives |
| 01/31/1996 | EP0694305A1 Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidinis |
| 01/31/1996 | EP0694303A1 Use of eliprodil and its enantiomers for the preparation of medicaments useful in the prevention of neuropathies induced by anticancer agents, e.g. paclitaxel |
| 01/31/1996 | EP0694302A1 Compositions containing insaturated fatty acids and an aldose reductase inhibitor for treatment of diabetic complications |
| 01/31/1996 | EP0694301A1 Synergistic combination containing at least a RXR specific ligand and a RAR alpha specific ligand |
| 01/31/1996 | EP0694300A1 Treatment of impotence |
| 01/31/1996 | EP0694299A1 The use of( a) bicycloheptane derivative(s) |
| 01/31/1996 | EP0694080A1 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome |
| 01/31/1996 | EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 01/31/1996 | EP0694038A1 Novel androgens and anabolic agents |
| 01/31/1996 | EP0694035A1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
| 01/31/1996 | EP0694033A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
| 01/31/1996 | EP0693932A1 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
| 01/31/1996 | EP0693929A1 Method for preventing keratocyte loss |